Marilena Vrana/LinkedIn
Jan 7, 2026, 13:40
Marilena Vrana Invites You to IPPC2026
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”Happy New Year!
There’s a lot to look forward to in 2026, but one thing I’m especially excited about is the official opening of IPPC2026 registration.
Save the date: registration opens 26 January
Bookmark.
The website will soon feature updated information about the 28-29 April programme in Milan, Italy.
From my behind-the-scenes vantage point, I can confidently say there’s a lot to look forward to, with programming focused on data, science, innovation, and more, bringing together insights shaping the future of plasma protein therapeutics.
I look forward to seeing you in Milan at IPPC2026!”
Stay updated with Hemostasis Today.
-
Apr 10, 2026, 16:36José Luis Ferreiro: After Stent Treatment in Heart Attack Patients How to Balance Bleeding and Clotting Risk
-
Apr 10, 2026, 15:54Niccolò Bitto: Answers to Some of the Most Frequently Asked Questions on Gene Therapy for Hemophilia
-
Apr 10, 2026, 15:52Tareq Abadl: Coombs Test Explained in a Simple and Clear Way
-
Apr 10, 2026, 15:10Jecko Thachil: Should We Consider Air Pollution as a Thrombophilic Marker?
-
Apr 10, 2026, 14:02Pablo Corral: Are Cholesterol and Inflammation Really Equal in Atherosclerosis?
-
Apr 10, 2026, 13:43Mohammed Alo։ How Low Should LDL Go in Secondary Prevention of Cardiovascular Disease
-
Apr 10, 2026, 13:21John Abraham: Telomere Biology Disorders – From Bench to Bedside
-
Apr 10, 2026, 01:19Heghine Khachatryan: When Vascular Fragility Defines Risk – Rethinking Hemostasis in LDS
-
Apr 9, 2026, 21:39Mechanisms of Immune Dysregulation in Immune Thrombocytopenia – JTH